Education
About Us
Working with TipRanks
Follow Us
Pfizer (PFE)
NYSE:PFE
PFE Stock Chart & Stats
$25.71
-$0.40(-1.47%)
At close: 4:00 PM EST
$25.71
-$0.40(-1.47%)
Day’s Range― - ―
52-Week Range$20.92 - $27.69
Previous CloseN/A
Volume12.20M
Average Volume (3M)81.66M
Market Cap
$146.18B
Enterprise Value$182.79B
Total Cash (Recent Filing)$14.98B
Total Debt (Recent Filing)$61.71B
Price to Earnings (P/E)15.0
Beta0.35
Next Earnings
Feb 03, 2026EPS Estimate
0.6Last Dividend Ex-Date
Nov 07, 2025Dividend Yield6.69%
Share Statistics
EPS (TTM)0.87
Shares Outstanding5,685,707,500
10 Day Avg. Volume69,687,380
30 Day Avg. Volume81,661,628
Financial Highlights & Ratios
PEG Ratio0.07
Price to Book (P/B)1.70
Price to Sales (P/S)2.36
P/FCF Ratio15.28
Enterprise Value/Market Cap1.25
Enterprise Value/Revenue2.91
Enterprise Value/Gross Profit4.09
Enterprise Value/Ebitda8.63
Forecast
1Y Price Target
$29.17Price Target Upside13.46% Upside
Rating ConsensusHold
Number of Analyst Covering15
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Earnings PerformancePfizer reported third-quarter earnings meeting consensus on revenue and beating expectations on EPS.
International Revenue GrowthPfizer's international revenues, excluding COVID, increased approximately 12% year-over-year, highlighting successful international commercial efforts.
Pipeline ExpansionThe company's recent transformative acquisitions, funded by COVID cash, are bolstering Pfizer's pipeline and contributing to future growth.
Bears Say
Financial ImpactThe transaction is expected to be financially dilutive through 2030.
Sales UnderperformancePaxlovid sales underperformed, potentially signaling another less severe COVID season lies ahead.
Trial DelaysThe MagnetisMM-5 trial and the PCV-25 adult valent pivotal trial have been delayed, affecting pipeline development.
Pfizer News
PFE FAQ
What was Pfizer’s price range in the past 12 months?
Pfizer lowest stock price was $20.91 and its highest was $27.69 in the past 12 months.
What is Pfizer’s market cap?
Pfizer’s market cap is $146.18B.
When is Pfizer’s upcoming earnings report date?
Pfizer’s upcoming earnings report date is Feb 03, 2026 which is in 65 days.
How were Pfizer’s earnings last quarter?
Pfizer released its earnings results on Nov 04, 2025. The company reported $0.87 earnings per share for the quarter, beating the consensus estimate of $0.633 by $0.237.
Is Pfizer overvalued?
According to Wall Street analysts Pfizer’s price is currently Undervalued.
Does Pfizer pay dividends?
Pfizer pays a Quarterly dividend of $0.43 which represents an annual dividend yield of 6.69%. See more information on Pfizer dividends here
What is Pfizer’s EPS estimate?
Pfizer’s EPS estimate is 0.6.
How many shares outstanding does Pfizer have?
Pfizer has 5,685,707,500 shares outstanding.
What happened to Pfizer’s price movement after its last earnings report?
Pfizer reported an EPS of $0.87 in its last earnings report, beating expectations of $0.633. Following the earnings report the stock price went down -1.444%.
Which hedge fund is a major shareholder of Pfizer?
Currently, no hedge funds are holding shares in PFE
Pfizer Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$29.17 (13.46% Upside)
$29.17 (13.46% Upside)
Blogger Sentiment
Bullish
PFE Sentiment 88%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 15.9M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▲ 0.5%
Last 30 Days ▲ 2.2%
Last 30 Days ▲ 2.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
6.98%
12-Months-Change
Fundamentals
Return on Equity
10.59%
Trailing 12-Months
Asset Growth
-4.90%
Trailing 12-Months
Company Description
Pfizer
Pfizer Inc. is a multinational pharmaceutical corporation headquartered in New York City, primarily engaged in the research, development, manufacturing, and marketing of healthcare products. The company operates in several sectors, including pharmaceuticals, vaccines, and consumer healthcare. Pfizer's core products encompass a wide range of therapeutic areas, including oncology, cardiology, immunology, and infectious diseases, with notable offerings such as the COVID-19 vaccine, Prevnar for pneumonia, and a variety of prescription medications.
PFE Company Deck
PFE Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Pfizer's earnings call was mixed, highlighting strategic advancements and financial performance, but also facing challenges in COVID-19 product revenue declines and ongoing legal issues with the Metsera acquisition.View all PFE earnings summariesPFE Revenue Breakdown
47.36% Primary Care
26.17% Specialty Care
24.54% Oncology
1.80% PFIZER CENTREONE
0.13% PFIZER IGNITE
PFE Stock 12 Month Forecast
Average Price Target
$29.17
▲(13.46% Upside)
Technical Analysis
Ownership Overview
0.02% Insiders
16.20% Mutual Funds
5.17% Other Institutional Investors
58.08% Public Companies and Individual Investors